Progenics Pharmaceuticals buy marge
Start price
12.10.17
/
50%
€6.50
Target price
25.12.18
€12.18
Performance (%)
-49.51%
End price
25.12.18
€3.28
Summary
This prediction ended on 25.12.18 with a price of €3.28. The BUY prediction by marge for Progenics Pharmaceuticals performed very badly with a performance of -49.51%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Progenics Pharmaceuticals | - | - | - | - |
| iShares Core DAX® | -3.809% | -1.472% | 6.060% | 52.755% |
| iShares Nasdaq 100 | 0.487% | 2.215% | 12.682% | 88.393% |
| iShares Nikkei 225® | -4.418% | 4.971% | 30.914% | 59.409% |
| iShares S&P 500 | 0.251% | 1.225% | 9.374% | 60.389% |
Comments by marge for this prediction
In the thread Progenics Pharmaceuticals diskutieren
marge stimmt der Buy-Einschätzung von tamam zu
marge stimmt am 12.10.2017 der Buy-Einschätzung von tamam mit dem Kursziel 13,5$ zu.Überschrift: PGNX with NDA for Azedra Submission 01.09.2017
(Laufzeit überschritten)
Stopped prediction by marge for Progenics Pharmaceuticals
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€7.59
29.07.15
29.07.15
€9.02
18.07.16
18.07.16
-39.43%
18.07.16
18.07.16
Progenics Pharmaceuticals
Start price
Target price
Perf. (%)
€7.55
20.07.15
20.07.15
€9.02
28.07.15
28.07.15
26.45%
28.07.15
28.07.15